CD4 and rheumatoid arthritis: Among the analyzed transcriptome sets of CD4+ cells, 24 belonged to RA patients treated with JAK-inhibitors (JAKi), which inflicted anti-inflammatory effects by abrogating signaling from numerous cytokine receptors [29].